Newcastle upon Tyne, United Kingdom

Kappusamy Saravanan


Average Co-Inventor Count = 12.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Newcastle upon Tyne, GB (2008 - 2010)
  • Bengaluru, IN (2010)

Company Filing History:


Years Active: 2008-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Kappusamy Saravanan

Introduction

Kappusamy Saravanan is an accomplished inventor based in Newcastle upon Tyne, GB. With a portfolio of three patents, he has made significant contributions to the field of biotechnology, particularly in the development of DNA-PK inhibitors.

Latest Patents

Saravanan's latest patents include innovative compounds described as DNA-PK inhibitors. These compounds are characterized by a complex formula that includes isomers, salts, solvates, chemically protected forms, and prodrugs. The detailed structure involves various functional groups such as hydrogen, alkyl groups, and heterocyclic rings, demonstrating his deep understanding of chemical interactions and pharmaceutical applications.

Career Highlights

Throughout his career, Saravanan has had the opportunity to collaborate with prominent companies in the pharmaceutical industry. He has worked with Kudos Pharmaceuticals Limited and Cancer Research Technology Limited, where his focus has been on advancing cancer treatment through innovative therapeutic compounds.

Collaborations

In his professional journey, Saravanan has collaborated with notable individuals such as Graeme Cameron, Murray Smith, and Niall Morrison Barr Martin. These partnerships reflect his commitment to teamwork and the collective pursuit of groundbreaking medical solutions.

Conclusion

Kappusamy Saravanan stands out as a prolific inventor whose work on DNA-PK inhibitors underscores the importance of innovation in the medical field. His contributions, through his patents and collaborations, not only reflect his expertise but also his dedication to improving healthcare outcomes. As he continues to push the boundaries of biotechnology, Saravanan remains a key figure in the quest for novel cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…